Johnson & Johnson (JNJ)
NYSE · Healthcare
Johnson & Johnson EPS 2017–2025
Johnson & Johnson annual/quarterly eps history and growth rate from 2017 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Johnson & Johnson eps for the quarter ending March 29, 2026 was $2.14, a 52.86% decrease year-over-year.
- Johnson & Johnson annual eps for 2025 was $11.03, a 90.50% increase from 2024.
- Johnson & Johnson annual eps for 2024 was $5.79, a 57.80% decrease from 2023.
- Johnson & Johnson annual eps for 2023 was $13.72, a 103.86% increase from 2023.
- Johnson & Johnson annual eps for 2023 was $6.73.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Johnson & Johnson EPS — FAQ
Johnson & Johnson (JNJ) eps over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Johnson & Johnson's eps?
Johnson & Johnson (JNJ) reported eps of $11.03 for fiscal 2025.
Where can I see JNJ's eps history?
The chart and table above show Johnson & Johnson's eps by year and by quarter, including the growth rate.